The Institute for Systems Genomics (ISG)
was established in November 2012 with a mission of promoting world-class research and training in genomics and personalized medicine.
The ISG leverages significant investment from the state, including the $865 million Bioscience Connecticut initiative, $172 million Tech Park program, $200 million Bioscience Innovation Fund, and $1.7 billion Next Generation Connecticut.
The dedicated faculty and staff of the ISG’s ecosystem are training the next generation of genome scientists through collaborative, vigorous, and innovative research programs in areas related to functional and systems genomics; computational biology and bioinformatics; human, mammalian, microbial, pharmacological, immunological, statistical, and population genomics; and educational, ethical, legal, and social implications of genomic science and medicine.
This Institute gives UConn another wonderful opportunity to become internationally prominent in the field of genomics, a discipline that is being recognized more and more for its importance in clinical medicine,” explains Marc Lalande
, professor and chairman of Genetics and Genome Sciences
at UConn Health, who was appointed chair of the university-wide planning committee to create the Institute and who will serve as its director.